FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W4378220757> ?p ?o ?g. }

• W4378220757 endingPage "882" @default.
• W4378220757 startingPage "882" @default.
• W4378220757 abstract "Background: Intraplaque hemorrhage (IPH) is a hallmark of atherosclerotic plaque instability. Biliverdin reductase B (BLVRB) is enriched in plasma and plaques from patients with symptomatic carotid atherosclerosis and functionally associated with IPH. Objective: We explored the biomarker potential of plasma BLVRB through (1) its correlation with IPH in carotid plaques assessed by magnetic resonance imaging (MRI), and with recurrent ischemic stroke, and (2) its use for monitoring pharmacotherapy targeting IPH in a preclinical setting. Methods: Plasma BLVRB levels were measured in patients with symptomatic carotid atherosclerosis from the PARISK study (n = 177, 5 year follow-up) with and without IPH as indicated by MRI. Plasma BLVRB levels were also measured in a mouse vein graft model of IPH at baseline and following antiangiogenic therapy targeting vascular endothelial growth factor receptor 2 (VEGFR-2). Results: Plasma BLVRB levels were significantly higher in patients with IPH (737.32 ± 693.21 vs. 520.94 ± 499.43 mean fluorescent intensity (MFI), p = 0.033), but had no association with baseline clinical and biological parameters. Plasma BLVRB levels were also significantly higher in patients who developed recurrent ischemic stroke (1099.34 ± 928.49 vs. 582.07 ± 545.34 MFI, HR = 1.600, CI [1.092–2.344]; p = 0.016). Plasma BLVRB levels were significantly reduced following prevention of IPH by anti-VEGFR-2 therapy in mouse vein grafts (1189 ± 258.73 vs. 1752 ± 366.84 MFI; p = 0.004). Conclusions: Plasma BLVRB was associated with IPH and increased risk of recurrent ischemic stroke in patients with symptomatic low- to moderate-grade carotid stenosis, indicating the capacity to monitor the efficacy of IPH-preventive pharmacotherapy in an animal model. Together, these results suggest the utility of plasma BLVRB as a biomarker for atherosclerotic plaque instability." @default.
• W4378220757 created "2023-05-26" @default.
• W4378220757 creator A5008417149 @default.
• W4378220757 creator A5009602483 @default.
• W4378220757 creator A5017917951 @default.
• W4378220757 creator A5019114814 @default.
• W4378220757 creator A5022417082 @default.
• W4378220757 creator A5040020632 @default.
• W4378220757 creator A5049302482 @default.
• W4378220757 creator A5067847626 @default.
• W4378220757 creator A5069577087 @default.
• W4378220757 creator A5073307706 @default.
• W4378220757 creator A5074287499 @default.
• W4378220757 creator A5077526216 @default.
• W4378220757 creator A5080311936 @default.
• W4378220757 creator A5080838497 @default.
• W4378220757 creator A5091664481 @default.
• W4378220757 date "2023-05-24" @default.
• W4378220757 modified "2023-10-08" @default.
• W4378220757 title "Biliverdin Reductase B Is a Plasma Biomarker for Intraplaque Hemorrhage and a Predictor of Ischemic Stroke in Patients with Symptomatic Carotid Atherosclerosis" @default.
• W4378220757 cites W1848861661 @default.
• W4378220757 cites W1961763960 @default.
• W4378220757 cites W1984508486 @default.
• W4378220757 cites W2030023706 @default.
• W4378220757 cites W2033004960 @default.
• W4378220757 cites W2033931260 @default.
• W4378220757 cites W2054258901 @default.
• W4378220757 cites W2058424678 @default.
• W4378220757 cites W2062544283 @default.
• W4378220757 cites W2087175050 @default.
• W4378220757 cites W2095819288 @default.
• W4378220757 cites W2103317372 @default.
• W4378220757 cites W2136099330 @default.
• W4378220757 cites W2137892592 @default.
• W4378220757 cites W2331042307 @default.
• W4378220757 cites W2346828640 @default.
• W4378220757 cites W2591804695 @default.
• W4378220757 cites W2605484715 @default.
• W4378220757 cites W2617390885 @default.
• W4378220757 cites W2745403241 @default.
• W4378220757 cites W2811122957 @default.
• W4378220757 cites W2885370462 @default.
• W4378220757 cites W2887311144 @default.
• W4378220757 cites W2920558304 @default.
• W4378220757 cites W2951566019 @default.
• W4378220757 cites W3005558203 @default.
• W4378220757 cites W3027114057 @default.
• W4378220757 cites W3029091573 @default.
• W4378220757 cites W3108604852 @default.
• W4378220757 cites W3127823157 @default.
• W4378220757 cites W3137943250 @default.
• W4378220757 cites W3192369307 @default.
• W4378220757 cites W3200921012 @default.
• W4378220757 cites W4225694335 @default.
• W4378220757 cites W4239955109 @default.
• W4378220757 cites W4252739453 @default.
• W4378220757 cites W4282982713 @default.
• W4378220757 doi "https://doi.org/10.3390/biom13060882" @default.
• W4378220757 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/37371462" @default.
• W4378220757 hasPublicationYear "2023" @default.
• W4378220757 type Work @default.
• W4378220757 citedByCount "0" @default.
• W4378220757 crossrefType "journal-article" @default.
• W4378220757 hasAuthorship W4378220757A5008417149 @default.
• W4378220757 hasAuthorship W4378220757A5009602483 @default.
• W4378220757 hasAuthorship W4378220757A5017917951 @default.
• W4378220757 hasAuthorship W4378220757A5019114814 @default.
• W4378220757 hasAuthorship W4378220757A5022417082 @default.
• W4378220757 hasAuthorship W4378220757A5040020632 @default.
• W4378220757 hasAuthorship W4378220757A5049302482 @default.
• W4378220757 hasAuthorship W4378220757A5067847626 @default.
• W4378220757 hasAuthorship W4378220757A5069577087 @default.
• W4378220757 hasAuthorship W4378220757A5073307706 @default.
• W4378220757 hasAuthorship W4378220757A5074287499 @default.
• W4378220757 hasAuthorship W4378220757A5077526216 @default.
• W4378220757 hasAuthorship W4378220757A5080311936 @default.
• W4378220757 hasAuthorship W4378220757A5080838497 @default.
• W4378220757 hasAuthorship W4378220757A5091664481 @default.
• W4378220757 hasBestOaLocation W43782207571 @default.
• W4378220757 hasConcept C126322002 @default.
• W4378220757 hasConcept C126838900 @default.
• W4378220757 hasConcept C127413603 @default.
• W4378220757 hasConcept C142724271 @default.
• W4378220757 hasConcept C143409427 @default.
• W4378220757 hasConcept C164705383 @default.
• W4378220757 hasConcept C185592680 @default.
• W4378220757 hasConcept C2780645631 @default.
• W4378220757 hasConcept C2781197716 @default.
• W4378220757 hasConcept C3020199598 @default.
• W4378220757 hasConcept C541997718 @default.
• W4378220757 hasConcept C55493867 @default.
• W4378220757 hasConcept C71924100 @default.
• W4378220757 hasConcept C78519656 @default.
• W4378220757 hasConcept C90924648 @default.
• W4378220757 hasConceptScore W4378220757C126322002 @default.
• W4378220757 hasConceptScore W4378220757C126838900 @default.
• W4378220757 hasConceptScore W4378220757C127413603 @default.
• W4378220757 hasConceptScore W4378220757C142724271 @default.

• next